Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Virtu Financial
VIRT
$5.1B
| $98.3M | 0.08% |
4,163,903
+3,416,803
| +457% | +$79.9M |
2020 Q1
1 quarter
|
|
252
HEICO Corp Class A
HEI.A
$30.9B
| $98M | 0.08% |
1,206,307
-109,893
| -8% | -$8.52M |
2013 Q2
28 quarters
|
|
|
VGR
253
DELISTED
Vector Group Ltd.
VGR
| $97.9M | 0.08% |
13,717,030
-701,682
| -5% | -$5.36M |
2013 Q2
28 quarters
|
|
254
Citigroup
C
$215B
| $97.6M | 0.08% |
1,910,720
+290,578
| +18% | +$13.8M |
2020 Q1
1 quarter
|
|
255
Cinemark Holdings
CNK
$4.26B
| $97.5M | 0.08% |
8,444,400
+3,427,349
| +68% | +$46.5M |
2018 Q3
7 quarters
|
|
256
Copa Holdings
CPA
$5.49B
| $97.4M | 0.08% |
1,926,146
+104,585
| +6% | +$4.82M |
2017 Q1
13 quarters
|
|
|
SCHW
257
Charles Schwab
SCHW
$168B
| $95.9M | 0.08% |
2,841,500
+408,500
| +17% | +$14.6M |
2019 Q4
2 quarters
|
|
258
Papa John's
PZZA
$641M
| $95.4M | 0.08% |
1,201,968
+362,000
| +43% | +$26.9M |
2019 Q1
5 quarters
|
|
259
Mercury Insurance
MCY
$5.67B
| $95.4M | 0.08% |
2,340,100
-29,800
| -1% | -$1.2M |
2015 Q3
19 quarters
|
|
260
Insulet
PODD
$9.33B
| $95.3M | 0.08% |
490,800
+186,800
| +61% | +$35.7M |
2019 Q2
4 quarters
|
|
261
HCA Healthcare
HCA
$96.3B
| $94.9M | 0.08% |
977,400
+427,500
| +78% | +$44.4M |
2018 Q1
9 quarters
|
|
262
Rio Tinto
RIO
$152B
| $94.5M | 0.08% |
1,681,532
+122,600
| +8% | +$6.21M |
2018 Q3
7 quarters
|
|
263
S&P Global
SPGI
$119B
| $93.5M | 0.08% |
283,805
-139,800
| -33% | -$42M |
2019 Q4
2 quarters
|
|
|
PCH
264
DELISTED
PotlatchDeltic
PCH
| $92.9M | 0.08% |
2,443,305
-99,008
| -4% | -$3.35M |
2013 Q2
28 quarters
|
|
265
Ecopetrol
EC
$34.8B
| $92.5M | 0.08% |
8,313,686
-151,100
| -2% | -$1.64M |
2013 Q2
28 quarters
|
|
266
L3Harris
LHX
$44.1B
| $92.2M | 0.08% |
+543,370
| New | +$102M |
2020 Q2
0 quarters
|
|
267
Chewy
CHWY
$7.6B
| $91.2M | 0.08% |
2,041,600
+1,549,913
| +315% | +$67.6M |
2020 Q1
1 quarter
|
|
268
IAMGOLD
IAG
$10.5B
| $91M | 0.08% |
23,037,800
-317,700
| -1% | -$1.09M |
2013 Q2
28 quarters
|
|
269
Canadian Imperial Bank of Commerce
CM
$98.2B
| $90.8M | 0.08% |
2,712,200
+247,472
| +10% | +$7.73M |
2013 Q2
28 quarters
|
|
270
Sempra
SRE
$52.4B
| $90.6M | 0.08% |
1,545,400
+679,228
| +78% | +$41.7M |
2018 Q4
6 quarters
|
|
271
Best Buy
BBY
$18.5B
| $90.6M | 0.08% |
1,037,758
-1,003,454
| -49% | -$76.1M |
2016 Q1
17 quarters
|
|
272
TFS Financial
TFSL
$4.54B
| $89.7M | 0.08% |
6,269,689
-60,933
| -1% | -$878K |
2013 Q2
28 quarters
|
|
273
Sea Limited
SE
$56.9B
| $89.5M | 0.08% |
+834,300
| New | +$60.4M |
2020 Q2
0 quarters
|
|
274
CSX Corp
CSX
$87.7B
| $88.6M | 0.08% |
3,809,772
-8,082,603
| -68% | -$179M |
2018 Q2
8 quarters
|
|
|
NVMI
275
Nova
NVMI
$11.3B
| $88.5M | 0.08% |
1,837,000
-49,300
| -3% | -$2.09M |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.